Research map: Surgical Management of PSMA PET-Positive Lymph Nodes in Prostate Cancer

Back to the article

Papers in this map

  1. PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews · Abigail M. Methley · 2014 · 2744 citations · Cited by this paper
  2. Modern Management of Fournier’s Gangrene · 2025 · Related
  3. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study · Michael S. Hofman · 2020 · 2057 citations · Cited by this paper
  4. Three-Dimensional Virtual Models in Robot Assisted Partial Nephrectomy: A Needed Tool in the Era of Precision Surgery · 2025 · Related
  5. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review · Nicola Fossati · 2017 · 547 citations · Cited by this paper
  6. Management of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis · 2026 · Related
  7. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol · Gerhardt Attard · 2021 · 388 citations · Cited by this paper
  8. Lower Urinary Tract Symptoms in Patients with Congenital Genitourinary Anomalies · 2025 · Related
  9. Diagnostic Accuracy of 68 Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection · Thomas A. Hope · 2021 · 361 citations · Cited by this paper
  10. A Comprehensive Review of Artificial Urinary Sphincters: History, Current Utilization, and Future Innovations · 2025 · Related
  11. Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2) · Robert Seifert · 2023 · 315 citations · Cited by this paper
  12. Artificial Intelligence Use in Medical Education: Best Practices and Future Directions · 2025 · Related
  13. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial · Jean Felipe Prodocimo Lestingi · 2020 · 252 citations · Cited by this paper
  14. Is Open Partial Nephrectomy Still an Option in the Robotic Era? · 2026 · Related
  15. Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis · Kit Mun Chow · 2023 · 191 citations · Cited by this paper
  16. Donor Bladder Inclusion in Kidney Transplantation: A Review of the Literature and our Clinical Experience · 2026 · Related
  17. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard · Armando Stabile · 2021 · 127 citations · Cited by this paper
  18. Rethinking Gleason 6 Prostate Cancer: Embracing PrNLMP for Precision and Progress · 2025 · Related
  19. Risk of metastatic disease on 68 gallium‐prostate‐specific membrane antigen positron emission tomography / computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer · John William Yaxley · 2019 · 119 citations · Cited by this paper
  20. Minimally Invasive Surgery in Solitary Kidneys with Renal Tumors: A Surgical Evolution · 2026 · Related
  21. The Will Rogers Phenomenon in Urological Oncology · Ofer Nathan Gofrit · 2007 · 118 citations · Cited by this paper
  22. Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study · Giorgio Gandaglia · 2022 · 101 citations · Cited by this paper
  23. External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter Study · Dennie Meijer · 2021 · 79 citations · Cited by this paper
  24. Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection · Karim A. Touijer · 2024 · 67 citations · Cited by this paper
  25. A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment · Elio Mazzone · 2025 · 58 citations · Cited by this paper
  26. Robot-assisted prostate-specific membrane antigen-radioguided surgery in primary diagnosed prostate cancer · William Gondoputro · 2022 · 54 citations · Cited by this paper
  27. SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis · Ken Herrmann · 2025 · 32 citations · Cited by this paper
  28. Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term Outcomes · Giorgio Gandaglia · 2018 · 31 citations · Cited by this paper
  29. The prognostic value of lymph node staging with prostate‐specific membrane antigen ( PSMA) positron emission tomography/computed tomography (PET/ CT) and extended pelvic lymph node dissection in node‐positive patients with prostate cancer · Dennie Meijer · 2022 · 24 citations · Cited by this paper
  30. Preoperative 68Ga-PSMA PET/CT defines a subgroup of high-risk prostate cancer patients with favorable outcomes after radical prostatectomy and lymph node dissection · Snir Dekalo · 2021 · 20 citations · Cited by this paper
  31. Baseline Nodal Status on 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial · Michael S. Hofman · 2024 · 18 citations · Cited by this paper
  32. Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer · Reha‐Baris Incesu · 2025 · 18 citations · Cited by this paper
  33. External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography · Giorgio Gandaglia · 2025 · 18 citations · Cited by this paper
  34. Prostate-specific Membrane Antigen–radioguided Surgery Facilitates Pelvic Lymph Node Dissection During Radical Prostatectomy for the Treatment of Locally Advanced Prostate Cancer with Regional Lymph Node Metastases · Lukas Lunger · 2023 · 17 citations · Cited by this paper
  35. Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study · Leonardo Quarta · 2024 · 17 citations · Cited by this paper
  36. Pelvic Lymph Node Dissection in Prostate Cancer: Evidence and Implications · Matthew J. Roberts · 2025 · 17 citations · Cited by this paper
  37. The Role of Robot-Assisted, Imaging-Guided Surgery in Prostate Cancer Patients · Leonardo Quarta · 2025 · 12 citations · Cited by this paper
  38. Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters · Elio Mazzone · 2023 · 11 citations · Cited by this paper
  39. Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate‐Risk Prostate Cancer Patients With Node‐Negative PSMA PET · Barış Esen · 2025 · 10 citations · Cited by this paper

Source: OpenAlex (CC0)